Abbott moves to acquire Exact Sciences in major $21 billion all-stock merger

- Abbott
- Exact Sciences
- Abbott
- Exact Sciences
Abbott moves to acquire Exact Sciences in major $21 billion all-stock merger

- Abbott
- Exact Sciences
- Abbott
- Exact Sciences

Abbott’s $21 billion acquisition of Exact Sciences aims to expand its diagnostics presence, accelerate cancer screening innovation, and contribute sizeable revenue gains by 2027.

- Abbott
- Exact Sciences
- Abbott
- Exact Sciences
- Abbott
- Exact Sciences
- acquisition
- healthcare
- stocks





